Interval training compared with continuous training in patients with COPD  by Arnardóttir, Ragnheiður Harpa et al.
ARTICLE IN PRESS
Respiratory Medicine (2007) 101, 1196–12040954-6111/$ - see fr
doi:10.1016/j.rmed.
Corresponding au
E-mail address: h
1Enheten fo¨r lung
2Avdelningen fo¨r k
3Enheten fo¨r sjukgInterval training compared with continuous training in
patients with COPD
Ragnheiður Harpa Arnardo´ttira,, Gunnar Bomana,1, Kjell Larssonb,
Hans Hedenstro¨mc,2, Margareta Emtnera,3aDepartment of Medical Sciences, Respiratory Medicine and Allergology, Uppsala University, Uppsala, Sweden
bLung and Allergy Research, National Institute of Environmental Medicine, Karolinska Institute,
SE-171 77 Stockholm, Sweden
cDepartment of Medical Sciences, Clinical Physiology, Uppsala University, Uppsala, Sweden
Received 22 July 2006; accepted 8 November 2006
Available online 26 December 2006KEYWORDS
Chronic obstructive
pulmonary disease;
Continuous training;
Endurance training;
Health-related quality
of life;
Interval training;
Rehabilitationont matter & 2006
2006.11.004
thor. Physiotherap
arpa.arnardottir@
medicin och allerg
linisk fysiologi, Ak
ymnastik, AkademSummary
The aim of this study was to compare the effects of interval training (3-min intervals) with
continuous training on peak exercise capacity (W peak), physiological response, functional
capacity, dyspnoea, mental health and health-related quality of life (HRQoL) in patients
with moderate or severe COPD.
Sixty patients exercised twice weekly for 16 weeks after randomisation to interval- or
continuous training. Target intensity was X80% of baseline W peak in the interval group
(I-group) andX65% in the continuous group (C-group). Patients were tested by spirometry,
ergometer cycle test, cardiopulmonary test and a 12min walk test. Dyspnoea was
measured by the dyspnoea scale from Chronic Obstructive Disease Questionnaire (CRDQ),
mental health by Hospital Anxiety and Depression scale (HAD) and HRQoL by the Medical
Outcomes Survey Short Form 36 (SF-36).
After training, W peak, peak oxygen uptake (VO2 peak) and exhaled carbon dioxide (VCO2
peak) increased significantly in both groups, no significant differences between the groups.
Minute ventilation (VE peak) increased only in the C-group. At identical work rates
(isotime) VO2, VCO2 and VE were significantly more decreased in the I-group than in the C-
group (po0.05). Functional capacity, dyspnoea, mental health, and HRQoL improved
significantly in both groups, no difference between the groups.Elsevier Ltd. All rights reserved.
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Interval versus continuous training in COPD 1197Interval training and continuous training were equally potent in improving peak exercise
capacity, functional exercise capacity, dyspnoea, mental health and HRQoL in patients
with moderate or severe COPD. At isotime, the physiological response to training differed
between the groups, in favour of the interval training.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Endurance training is one of the cornerstones in pulmonary
rehabilitation and improves both exercise capacity and health-
related quality of life (HRQoL).1 Although endurance training in
COPD has been extensively studied, there are still questions to
be answered regarding training mode, intensity and duration.
Most exercise programmes have been based mainly on
endurance training with continuous load. High-intensity training
has more effect on exercise capacity than low-intensity
training2 but in patients with severe COPD it can be difficult
to sustain high-intensity by the continuous training modality.3,4
Dynamic lung hyperinflation (air-trapping) increases progres-
sively during continuous exercise in patients with COPD and
contributes importantly to their exercise intolerance.5,6
Interval exercise induces less dynamic hyperinflation than
continuous exercise in COPD.7,8 This could enable the patients
to exercise at a higher intensity and thereby enhance their
benefits from physical training. In healthy subjects, interval and
continuous training yield similar training effects.9 Few, small
studies have compared interval training with continuous training
in patients with COPD and the results are somewhat incon-
sistent.10–12 Coppoolse et al. compared continuous training with
a mixed programme of interval and continuous training and
found that peak exercise capacity (W peak) increased only by
the mixed training whereas peak oxygen uptake (peak VO2)
increased only following continuous training.10 Vogiatzis et al.,
however, found that both continuous and interval training
increased W peak, minute ventilation (VE) and HRQoL, but no
significant increase in VO2 peak was observed.
11 The same group
found comparable changes in peripheral muscle adaptations by
continuous and interval training.12 Interval training can be
conducted in various ways. Coppoolse et al. used bursts of 1min
at 90% versus 2min at 45% of baseline W peak, whereas
Vogiatzis et al. used 30 s at 100% of baseline W peak versus 30 s
rest.10–12 The duration of intervals can be of importance, as well
as the intensity, and some evidence suggests that long intervals
are more efficient than short intervals in healthy, young
people.13 More studies are needed on the effects of different
length and intensities of intervals for patients with COPD.
The primary aim of the present study was to compare the
effects on W peak of continuous training with interval
training comprising 3-min intervals. Secondary aims were to
compare the physiological responses to the two training
modes and their effects on functional capacity, dyspnoea,
mental health and HRQoL.
Methods
Study subjects
Patients with moderate or severe COPD according to the
British Thoracic Society guidelines14 were consecutivelyinvited to take part in the study when being referred for
training to the Physiotherapy Unit of the Pulmonary Section
at the Akademiska Hospital, Uppsala and at the County
Hospital in Va¨stera˚s, Sweden. All were smokers or ex-
smokers. The study was approved by the Medical Ethics
Committee of Uppsala University and all subjects gave
informed consent. Inclusion criteria were COPD with forced
expiratory volume in 1 s (FEV1)o60% of predicted value and
FEV1/VC (vital capacity) o0.7 after bronchodilatation.14
Exclusion criteria were other diseases that could interfere
with exercise such as ischemic coronary disease and
musculo-skeletal problems.
Study design
At baseline and after 16 weeks of training, lung function
tests, incremental cycle ergometer tests, semi-steady-state
cardiopulmonary exercise tests with gas exchange analysis
and 12min walk tests were performed and HRQoL was
assessed. Patients were stratified according to disease
severity, with FEV1 X 40% of the predicted value defined
as moderate disease, and FEV1 o40% predicted as severe
disease, according to the BTS guidelines.14 After stratifica-
tion the patients were randomised in blocks of four by the
closed envelope method into training with either interval
(I-group) or continuous (C-group) load. Training sessions
were twice a week for 16 weeks, session duration
approximately 90min. A criterion for fulfilling the training
was participation in at least 24 of the 32 sessions.
Testing
Lung function was measured with a Masterlab Trans
spirometer, Masterlab Body Plethysmograph and Masterlab
Transfer (Erich Jaeger AG, Wu¨rzburg, Germany) in accor-
dance with the ATS guidelines.15 Swedish reference values
were used.16,17
A symptom-limited incremental cycle ergometer test
(Case 8000 Exercise Testing System, GE Medical Systems,
Milwaukee, USA) with continuous ECG-registration was
conducted to measure peak work load (W peak). The
patients started pedalling at 20W and the load was
increased by 10W every minute until exhaustion. Oxygen
saturation was measured by a pulsoximeter (SpO2, Optovent
Respons) and heart rate and breathing frequency were
registered every minute during exercise. Systolic blood
pressure, subjective ratings of perceived exertion (Borg RPE
scale) and dyspnoea (Borg CR-10 scale) were recorded every
second minute.18,19 All variables were measured before and
1, 2, 4 and 10min after exercise.
A semi-steady-state cardiopulmonary exercise test with
breath-by-breath gas exchange analysis (ergospirometry)
was performed by all patients recruited at one of the
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ratings of perceived exertion and dyspnoea were made as
described above. The patients wore a mask with a turbine
for gas exchange analysis (Oxycon Sigma, Jaeger, Germany)
measuring VO2, VCO2 (bicarbonate) and VE. After recording
steady-state measurements at rest (approximately 4min of
registration at rest) the patient began pedalling at 20W. The
load was kept constant until the ventilation and oxygen
uptake reached a plateau, on average 3–4min at each level
(hence semi-steady-state, as conventional steady-state
requires at least 6min at each level). To keep testing time
within reasonable limits (10–15min) the load was increased
by 5, 10, 20 or 30W depending on the outcome of the first
test. This was continued until exhaustion. The test
procedure was identical (same steps of load) before and
after the training intervention for each patient. The test
was performed 30min after the incremental cycle test (later
if needed for all resting parameters to be stable at pre-
exercise levels).
Twelve-minute walk tests were performed in a level
corridor (34m) as described by McGavin.20 No encourage-
ment was given and the supervisor did not walk alongside
the patient. The patient was asked to cover as much ground
as possible in 12min in his own speed, pausing if necessary.
The patient was told the time after 4, 6, 8, 10 and 11min.
Each patient repeated the 12-min walk test on a different
day within 1week at the same time of day, with the same
supervisor. This was done both before and after training.
Dyspnoea during activities of daily life was measured by
the dyspnoea scale from the Chronic Respiratory Disease
Questionnaire (CRDQ).21 The patient scores on a 7-graded
scale the dyspnoea usually experienced during five self-
chosen activities of his life. A higher score indicates less
dyspnoea.
Mental health was assessed by the Hospital Anxiety and
Depression scale (HAD).22 The score-range in HAD is 0–21, a
higher score indicating worse mental health.
General HRQoL was assessed by the Medical Outcomes
Survey Short Form 36 questionnaire (SF-36).23 The SF-36 has
eight domains: physical function, role physical, bodily pain,
general health, vitality, social function, role emotional and
mental health. For each domain the score is from 0 to 100
(most healthy).Exercise training
Exercise training was performed on an out-patient basis. All
sessions started with ergometer cycling. In the I-group the
target training intensity wasX80% of the baseline W peak in
the ‘‘uphill’’ intervals and 30%–40% of the baseline W peak in
the ‘‘downhill’’ intervals. All intervals in the I-group were
3min, i.e. the high- and low-intensity intervals were equally
long. In the C-group the target training intensity was X65%
of baseline W peak. For warming up and cooling down both
groups cycled at 30%–40% of baseline W peak for 6min in the
beginning and at the end of each session. Total cycle time
was 39min in both groups, each session to allow for five
‘‘uphills’’ in the I-group, separated by four ‘‘downhills’’ and
with warming up before and cooling down afterwards.
Consequently, the C-group cycled for 27min each session at
their effective training load. In both groups, exercise loadwas kept as high as tolerated at all times, above the target
values when possible. All patients scored their dyspnoea and
perceived exertion on the Borg scales CR-10 and RPE every
3min. Target scores for dyspnoea and exertion were X5
and/or X15, respectively, after the ‘‘uphill’’ bursts and at
the end of the continuous load. Target intensity, patients’
score and the physiotherapist’s observation of the patient
steered the adjustment of exercise load. All patients were
taught to use pursed-lip-breathing technique during
exercise.
After cycling, the session proceeded once a week with
callisthenics and relaxation and once a week with resistance
training. The callisthenics were done in the sitting position
and consisted of flexibility exercises for thorax, neck and
shoulders. The relaxation was ad modum Jacobson.24 The
resistance training included exercises for upper and lower
limbs as well as the abdominal muscles (10 repetitions, two
sets, at about 70% of 1 RM). Callisthenics, relaxation and
resistance training were the same in both groups. Patients
who desaturated on exercise (SpO2 o90%) were given
supplemental oxygen during training sessions.
Statistical analysis
The results are expressed as mean and standard deviation
(SD) in text and tables but as mean and standard errors of
the mean (SEM) in figures. For analysis we used Student’s
t-test for paired and unpaired observations and ANOVA-
repeated measures (one-way for intra-group analysis and
two-way for inter-group analysis). For subjective ratings and
unevenly distributed data the Wilcoxon’s signed rank test
(intra-group) and the Mann–Whitney U-test (inter-group)
were applied. Calculating with an inter-group difference of
training-induced W peak difference of 5W, 35 patients in
each group would yield a power of 80% if a ¼ 0:05.
Results
One hundred patients were included, and 60 patients
completed the programme (Table 1). The age range was
43–80 years and the range in FEV1 (% predicted value) was
14%–59%. Ten patients were still smokers (4 in the I-group).
The patients who completed the programme had a mean
attendance rate of 2973 of 32 possible sessions (no
difference in attendance rate between the two training
groups). The 40 patients who did not complete 24 sessions
(and were thus excluded) had higher functional residual
capacity (5.571.2 l versus 4.871.3 l; po0.05), residual
volume (4.371.2 l versus 3.871.1 l; po0.05) and total lung
capacity (7.071.3 versus 6.271.3; po0.01) than those who
completed the programme, indicating a more severe disease
in the drop-outs. No other baseline values were different
from the patients who completed the programme. The
reason for drop-out were exacerbations ðn ¼ 24Þ, lack of
motivation or transport problems ðn ¼ 10Þ, other diseases
ðn ¼ 5Þ and family problems ðn ¼ 1Þ.
Exercise training
As the pattern of exercise was different, consequently the
exercise intensity between the two groups was significantly
ARTICLE IN PRESS
Table 1 Baseline characteristics of the 60 subjects that fulfilled the programme.
I-group, n ¼ 28 C-group, n ¼ 32
Gender (F:M) 25:3 26:6
Age (years) 65 (7) 64 (8)
BMI (kg/m2) 24.1 (5.0) 23.5 (4.4)
Packyears (pk/day years) 33 (17) 35 (19)
TLC (liters) 6.0 (1.0) 6.5 (1.5)
TLC (% pred.) 111 (18) 112 (21)
FRC (liters) 4.6 (1.0) 5.0 (1.5)
FRC (% pred.) 142 (33) 145 (41)
RV (liters) 3.7 (0.9) 3.9 (1.2)
RV (% pred.) 184 (52) 188 (63)
VC (liters) 2.3 (0.6) 2.6 (1.0)
VC (% pred.) 70 (16) 69 (22)
FEV1 (liters) 0.9 (0.3) 0.8 (0.3)
FEV1 (% pred.) 35 (13) 32 (10)
DLCO (% pred.) 55 (18) 46 (16)
Peak Watt (% pred.) 55 (17) 53 (17)
I-group, interval group; C-group, continuous group; F:M, female vs. male gender; % pred., as a percentage of the predicted value; BMI,
body mass index; TLC, total lung capacity; FRC, functional residual capacity; RV, residual volume; VC, vital capacity; FEV1, forced
expiratory volume in 1 s; DLCO, diffusion capacity of carbon monoxide.
Mean (SD).
Interval versus continuous training in COPD 1199different (po0.05; Fig. 1A). Target exercise intensity
was reached at session 575 for the I-group (X80% of W
peak) and at session 977 for the C-group (X 65% of W
peak), but the difference in time to reach target intensity
was not significant between the groups ðp ¼ 0:06Þ.
The exercise workload in the high-intensity bursts in the
I-group reached 100% of baseline W peak at session 14.
Furthermore, during high-intensity intervals at the last
sessions, exercise W exceeded baseline W peak (po0.05)
(Fig. 1A). At the last high-intensive interval of cycle
training sessions, mean exertion rating was 15.871.4
in the I-group and 15.172.1 in the C-group ðp ¼ 0:08Þ.
Ratings of dyspnoea at the same time were 5.871.4
and 5.271.4, respectively ðp ¼ 0:14Þ. There was no sig-
nificant difference between the second and the last week of
training in these ratings, indicating adequate progression in
exercise load as exercise capacity increased during the
study.
Total cycle-workload (the sum of Wmin) per session
revealed no significant difference in total workload between
the groups, though a tendency towards a higher total work
in the C-group was observed ðp ¼ 0:07Þ. Total workload
increased significantly with time (po0.0001) in both groups
(Fig. 1B).
In the resistance training part (the same procedure in
both groups) both groups increased the resistance loads
successively during the study (po0.001) both for arm and
leg exercises, with no difference between the groups
(p ¼ 0:6 and 0.3, respectively).
During exercise, 17 patients (7 in I-group) were
given supplemental oxygen via a nasal cannula, just
enough to keep the SpO2 X90%. Mean oxygen rate was1.370.7 l/min, no significant difference between the groups
ðp ¼ 0:5Þ.Exercise capacity
W peak increased significantly (po0.001) in both groups
after 16 weeks of training by 1177W in the I-group and by
11712W in the C-group (Table 2). Peak levels of heart rate,
breathing frequency, SpO2 and subjective ratings of dys-
pnoea and exertion did not change. VO2 peak and VCO2 peak
increased in both groups (Table 2) whereas VE peak
increased significantly in the C-group only (Table 2). No
difference between the groups was found in any post-
exercise peak values or in the change from baseline peak
values.
Measurements at isotime, i.e. at identical work rates
before and after training, showed significantly lower heart
rate, perceived exertion and dyspnoea after training in both
groups. Significantly lower VO2 (777158ml/min, po
0.05), VCO2 (1107169ml/min, po0.05), VE (3.67
5.6 l/min, po0.01) and breathing frequency (373
breaths/min, po0.01) compared to baseline emerged
in the I-group only and these changes from baseline di-
ffered significantly between the groups (po0.05; Table 3,
Fig. 2).
Functional exercise capacity, i.e. 12min walking
distance (12MWD) increased significantly in both
groups, with no significant difference between the groups
(Table 2).
Fifteen patients exceeded the anaerobic threshold
(VCO2 4 VO2 during ergospirometry) before training
ARTICLE IN PRESS
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Figure 1 The development in exercise load during time. Every
second session is shown. Filled circles: I-group, n ¼ 28; open
circles: C-group, n ¼ 32. Mean and SEM. (A) The exercise-load
expressed as percent of peak Watt at baseline during the high-
load bursts in the I-group and during continuous load in the C-
group at the different sessions throughout the study. (B) The
total amount of work in each of the groups at training sessions
2–24.
R.H. Arnardo´ttir et al.1200(7 in the I-group) and 16 patients after training (8 in the
I-group). Nine of these were the same both before and after
training. No difference in the effect of training was seen in
the patients who exceeded the anaerobic threshold com-
pared to the others, nor in the patients with supplemental
oxygen compared to the others.Dyspnoea, mental health and HRQoL
Dyspnoea during daily activities decreased significantly after
training in both groups (Table 4). Mental health (anxiety and
depression) was also significantly improved by training in
both groups. The domains ‘‘vitality’’ and ‘‘mental health’’
from SF-36 significantly improved in both groups, whereas
‘‘social function’’ and ‘‘general health’’ improved signifi-cantly in the I-group only (Table 4). There was, however, no
significant difference between the groups in the change
from baseline in any of the questionnaires. Lung function did
not change during the study.Discussion
In the present study it was demonstrated that 3-min interval
training is an efficient training mode for COPD patients. This
is clinically relevant, as 3-min intervals are easily conducted
in group training sessions for patients with COPD. Interval
and continuous training equally improved W peak, on
average 11W. The improvement was similar to previous
studies25,26 and larger than 5.5W which was the weighted
mean difference of the 15 studies included in the meta-
analysis by Lacasse et al.1 The improvement in W peak was
consistent with the findings of Vogiatzis et al.11 but differed
from the results of Coppoolse et al., as W peak increased
only in the I-group in their study.10 In both our groups, peak
values of VO2 and VCO2 increased significantly, whereas VE
peak increased in the C-group only. This is not in agreement
with the findings of Vogiatzis et al., who found no increase in
peak values of VO2 or VCO2 in either group, but increased VE
peak in both groups.11
At isotime, VO2, VCO2 and VE were significantly more
decreased in the I-group, indicating that the interval
training resulted in a larger reduction in oxygen cost and
ventilation at sub-maximal exercise than the continuous
training. No decrease in VO2, VCO2 or VE was found in the C-
group at isotime. This is in line with the findings of
Coppoolse et al.,10 who found that only interval training
decreased the VO2/W ratio, but differs from Vogiatzis et al.,
who found that VO2, VCO2 and VE decreased significantly in
both groups at isotime (no difference between the groups),
as well as breathing frequency.11 Isotime breathing fre-
quency was only decreased in our I-group and we consider
this to be the most likely explanation for the decreased VE at
isotime. Decreased ventilatory demand and oxygen con-
sumption at isotime is an indicator of more increased sub-
maximal work capacity by endurance testing,27 but as no
endurance tests were done in the present study, it is not
clear whether the difference between the groups at isotime
would have affected endurance time. Markedly decreased
dyspnoea, perceived exertion and heart rate were found in
both groups at isotime, in agreement with Vogiatzis.11
As shown above, our study confirms several findings from
the quoted studies, but there are some prominent incon-
sistencies as well.10–12 We can only speculate about the
reasons for these inconsistencies. Firstly, the length and
intensity of the intervals differed between our study and
the studies quoted above10–12 which might affect the
results, as changes in peak oxygen uptake and ventilatory
demand during exercise are larger after training with
intervals lasting 3–5min than after short-interval training
in healthy people.13,28 Secondly, in our study, training
sessions included resistance training once a week, which
might have enhanced the response to training.29,30 Thirdly,
85% of our patients were women whereas in the other
studies 83%–100% of the patients were men.10–12 Recent
studies indicate that the skeletal muscles adapt to COPD
differently in men and women.31,32 As both interval and
ARTICLE IN PRESS
Table 2 Results (peak values) from incremental cycle testing, 12min walking tests and semi-steady-state tests with
ergospirometry.
I-group C-group
Baseline 16 weeks Baseline 16 weeks
Incremental cycle test n ¼ 28 n ¼ 32
Watt 61 (20) 72 (22) 64 (22) 75 (27)
Heart rate (beats/min) 131 (2) 132 (20) 134 (17) 133 (19)
Breathing frqv. (breaths/min) 31 (4) 30 (6) 30 (7) 30 (8)
Dyspnoea (Borg CR-10) 7.9 (2.0) 7.2 (1.4) 7.9 (1.6) 7.2 (1.6)
Exertion (Borg RPE) 17.3 (1.5) 17.0 (1.2) 17.3 (1.3) 16.7 (1.3)
Walking test n ¼ 28 n ¼ 32
12MWD (m) 834 (185) 909 (203) 870 (165) 964 (155)
Ergospirometry n ¼ 25 n ¼ 28
VO2 peak (ml/min) 988 (286) 1041 (299)
 973 (292) 1119 (297)
VCO2 peak (ml/min) 944 (326) 999 (363)
 942 (346) 1091 (349)
VE peak (l/min) 34.9 (10.8) 36.0 (11.3) 34.8 (10.1) 38.4 (9.3)

I-group, interval-group; C-group, continuous-group; Watt, exercise capacity on incremental cycle test; breathing frqv., breathing
frequency; dyspnoea, dyspnoea score on the Borg CR-10 scale; exertion, score on the Borg-RPE-scale; 12MWD, 12min walking
distance; VO2 peak, oxygen uptake; VCO2, carbondioxide in exhaled air; VE, minute ventilation. Difference from baseline within group:
Mean (SD).
po0.05,
po0.01,
po0.001.
Table 3 Effect of training on the responses to exercise at identical work rate and duration (isotime) in the incremental cycle
test and the semi-steady-state test.
I-group C-group
Baseline 16 weeks Baseline 16 weeks
Incremental cycle test n ¼ 28 n ¼ 32
Watta 60 (21) 63 (24)
Heart rate (beats/min) 130 (20) 125 (18) 134 (15) 127 (16)
Breathing frqv. (breaths/min) 31 (4) 28 (6) 30 (7) 28 (7)
Dyspnoea (Borg CR-10) 7.9 (2.0) 5.4 (1.4) 7.8 (1.7) 5.3 (2.0)
Exertion (Borg RPE) 17.3 (1.4) 14.9 (1.7) 17.1 (1.3) 14.4 (2.3)
Ergospirometry n ¼ 25 n ¼ 28
Wattb 45 (20) 49 (24)
VO2 (ml/min) 987 (288) 912 (279)
,y 985 (283) 1011 (258)
VCO2 (ml/min) 943 (328) 834 (313)
,y 925 (346) 937 (349)
VE (l/min) 34.9 (10.9) 31.2 (9.9)
 34.4 (10.2) 34.0 (7.9)
I-group, interval-group; C-group, continuous group; breathing frqv., breathing frequency; dyspnoea, dyspnoea score on the Borg CR-10
scale; exertion, score on the Borg-RPE-scale; VO2, oxygen uptake; VCO2, carbondioxide in exhaled air; VE, minute ventilation.
Mean (SD).
po0.05,
po0.01,
po0.001 within group,
ypo0.05 between groups.
aIsotime load in the incremental test.
bIsotime load in the semi-steady-state test.
Interval versus continuous training in COPD 1201continuous training induce changes in peripheral muscle,12
the different gender distribution between the studies might
make a difference.Functional exercise capacity (12MWD) increased similarly
in both groups. In most studies on physical training for COPD
patients the 6min walk test has been used and therefore our
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Figure 2 The change from baseline at peak performance and at isotime after training, expressed as percent (mean and SEM). Black
bars: interval-group, white bars: continuous-group. All shown bars indicate a significant change within group, except those labelled
‘‘NS’’. y, po0.05 between the groups; 12MWD, 12min walking distance; Watt, exercise capacity; VO2, oxygen uptake; VCO2, carbon
dioxide in exhaled air; VE, minute ventilation; CR-10, dyspnoea; RPE, perceived exertion.
Table 4 Health-related quality of life at baseline and after 16 weeks of training.
I-group, n ¼ 28 C-group, n ¼ 32
Baseline 16 weeks Baseline 16 weeks
Dyspnoea (CRDQ) 16.5 (4.1) 19.2 (5.2) 14.8 (3.0) 18.5 (4.9)
Anxiety (HAD) 7.2 (4.5) 5.2 (4.3) 6.9 (3.5) 4.8 (3.9)
Depression (HAD) 5.8 (3.6) 4.3 (3.6) 5.4 (3.2) 4.0 (3.0)
SF-36
Physical function 37.0 (14.2) 41.1 (22.4) 41.7 (19.6) 38.3 (19.5)
Role physical 32.6 (35.7) 35.4 (39.6) 35.6 (41.9) 33.7 (40.0)
Bodily pain 68.9 (16.5) 79.2 (22.9) 69.6 (23.9) 75.7 (23.9)
General health 33.4 (16.5) 41.2 (20.2) 39.5 (17.2) 46.3 (21.9)
Vitality 46.7 (23.8) 54.8 (24.7) 44.8 (21.4) 56.9 (21.2)
Social function 66.0 (26.1) 75.0 (23.6) 70.7 (23.4) 73 (24.4)
Role emotional 48.4 (44.7) 61.3 (40.5) 53.8 (45.3) 64.0 (45.1)
Mental health 65.1 (25.0) 75.8 (17.3) 69.1 (19.5) 75.7 (16.9)
I-group, interval-group; C-group, continuous group; CRDQ, Chronic Respiratory Disease Questionnaire dyspnoea scale (0–35); HAD,
Hospital Anxiety and Depression Scale (0–21); SF-36, Short Form 36 (0–100).
Mean (SD).
po0.05,
po0.01 within group.
R.H. Arnardo´ttir et al.1202results could not be directly compared with these studies. In
a meta-analysis, the mean weighted difference before and
after training was 49m in the 6min walk test.1 In our study,
12MWD increased by 75 and 94m, respectively, in the two
groups and we consider this increase to be close to the
increase in the 6min test quoted above.
At baseline, most of the scores indicated poor mental and
physical health status and HRQoL. Compared to the results
from the Swedish Health Survey II,33 the SF-36 scores in both
groups were very low. In both groups dyspnoea, anxiety,depression and HRQoL improved after training. The im-
provement in dyspnoea was above the clinically significant
difference for this domain.34,35 The distinct decrease in
anxiety and depression after training was interesting, as
those symptoms are common problems in COPD, and anxiety
in combination with low HRQoL is an important factor for
rehospitalisation in COPD.36,37 As training improved anxiety
and HRQoL in both groups, training after hospitalisation may
decrease the risk of readmissions. This is supported by Man
et al. who recently showed that early rehabilitation after
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Interval versus continuous training in COPD 1203hospitalisation is safe and effective.38 The main changes in
SF-36 scores were similar in both groups, with improvements
mainly in the more psychological domains. The absence of
improvement in the physical domains of the scale was not in
line with increased physical performance. It has previously
been found that HRQoL correlates poorly to physical
performance.35,39
The difference in training intensity between the groups
was fairly constant throughout the study, with a similar
increase ratio in both groups. The successive increase in
workload during the study is an example of the usefulness of
the Borg scales for dosing exercise. We did not initially
choose the workload in order to obtain the same total
workload in both groups, as we wanted to investigate the
effects of the two different training modalities when both
groups were exercising as hard as possible. However, total
workload was not significantly different between the groups
throughout the study.
Our results show, in line with Vogiatzis,11 that two training
sessions per week are beneficial to patients with COPD
although others have found this to be insufficient.40 We
noticed a much larger training effect in the current study
than in a previous investigation of training twice a week for
8 weeks,41 indicating that the total number of training
sessions might be as important as the number per week. In
the present study the training intensity was still increasing
after 24 sessions, implying that the subjects might have
improved even further with more prolonged training. The
optimal training duration is still not known for these
patients and possibly the limited training time offered
might contribute to somewhat poor long-term results after
training in follow-up studies.41–43
In Sweden, women have caught up with men in the
prevalence of and mortality in COPD.44 The majority of
women in our study reflects the gender distribution referred
to pulmonary rehabilitation at our clinics during the time of
the study. We can only speculate that this might indicate
that women were either more often offered referral to
pulmonary rehabilitation by their physicians or were more
likely to accept such an offer than the men.
As expected, the drop-out ratio was high in the current
study which is in agreement with some other intervention
studies of patients with severe COPD.45,46 This may have
affected the power, as less than 35 patients in each group
completed the study. The drop-outs suffered from more
severe disease than those who completed and the main
reason for drop-out was exacerbations, which occur more
frequently in severely ill patients.
We conclude that 3-min interval training and continuous
training were equally potent in increasing W peak in patients
with moderate to severe COPD. This was true for functional
exercise capacity, dyspnoea, mental health and HRQoL as
well. Differences in physiological response to training at
isotime emerged between the groups, in favour of the
interval training.Acknowledgements
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